Evaluation of a Shared Decision Making Portal for Pediatric Asthma

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Completed
CT.gov ID
NCT01715389
Collaborator
(none)
81
1
2
27.9
2.9

Study Details

Study Description

Brief Summary

This pilot intervention study will test the feasibility and acceptability and explore the outcomes of a primary care-based shared decision making (SDM) electronic medical record (EMR)-based portal that provides education, elicits and tracks patients/families' treatment concerns and goals, assesses symptoms and asthma control over time, and provides decision support to clinicians and families.

Condition or Disease Intervention/Treatment Phase
  • Other: MyAsthma Patient Portal
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
81 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Study Start Date :
Nov 1, 2012
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Parents in the intervention group will use the MyAsthma Patient Portal to receive enhanced educational information on asthma and its treatment, identify concerns and goals related to asthma treatment, track progress toward goals and management of concerns monthly, and track asthma symptoms monthly. Clinicians seeing intervention families at office visits will have access to information from the portal including concerns, goals, progress toward goals, and tracking of asthma symptoms.

Other: MyAsthma Patient Portal
Parents in the intervention group will use the MyAsthma Patient Portal to receive enhanced educational information on asthma and its treatment, identify concerns and goals related to asthma treatment, track progress toward goals and management of concerns monthly, and track asthma symptoms monthly. Clinicians seeing intervention families at office visits will have access to information from the portal including concerns, goals, progress toward goals, and tracking of asthma symptoms.

No Intervention: Control

The control group will be signed up for MyChart but not use the MyAsthma Patient Portal. This group will be referred to asthma educational content on the CHOP website, complete study measures and otherwise, receive standard care.

Outcome Measures

Primary Outcome Measures

  1. Acceptability of the intervention to parents and clinicians [24 months]

    Parents and clinicians will be asked a series of open-ended questions regarding themes including satisfaction, acceptability and unintended consequences of using the portal for intervention subjects and using MyChart in general for control subjects. Subjects will also be asked a series of Likert-scaled questions related to satisfaction.

Secondary Outcome Measures

  1. Shared decision making [Baseline]

    Joint participation in decision-making will be measured by the Observing Parent Involvement (OPTION) scale.

  2. Parent Activation [0 months, 3 months, 6 months]

    Parent activation will be measured by the Parent Patient Activation Measure (PPAM).

  3. Goal Attainment [0 months, 3 months, 6 months then Monthly]

    Parents will identify one or more goals at the study start. Progress toward the goal(s) will be assessed at 3 and 6 month follow-up using Likert-scaled items for the control group, and monthly through use of the portal for the intervention group.

  4. Asthma-Related Quality of Life [0 months, 6 months]

    Asthma-related quality of life will be measured using The Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF)

  5. Asthma Control [0 months, 6 months]

    Asthma control will be assessed using the Pediatric Asthma Control Tool (PACT)

  6. Asthma-related Utilization [3 months, 6 months]

    Utilization will be measured by parent report and chart review by the research team of the following: Any primary care or subspecialty outpatient encounters relevant to asthma care, asthma-specific acute primary care visits or Urgent Care Center visits, asthma-specific Emergency Room visits, asthma-specific hospital admissions.

  7. Asthma Medication Adherence/Receipt [6 months]

    Prescribed medications for the treatment and management of asthma Type and number of prescriptions for asthma

  8. Feasibility of Recruitment [24 months]

    The feasibility of recruitment will be assessed by examining the proportion of all families contacted who meet enrollment criteria and the proportion of families meeting enrollment criteria who enroll.

  9. Feasibility of Follow-up [24 months]

    The feasibility of follow-up will be assessed by the proportion of enrolled families who complete each study measure.

  10. Feasibility of Portal Use [24 months]

    The feasibility of portal use will be assessed by the level of research team/other outside support needed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parents/legal guardians of children aged 6-12 with persistent asthma, currently receiving chronic maintenance therapy, cared for at a study practice, with consistent access to a computer with an internet connection where they feel comfortable accessing MyChart (patient portal)

  • Clinician at study site

Exclusion Criteria:
  • parents non-english speaking

  • child's primary care provider at the time of enrollment is a pediatric resident

  • not meeting inclusion criteria

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Children's Hospital of Philadelphia

Investigators

  • Principal Investigator: Alexander G Fiks, MD, MSCF, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01715389
Other Study ID Numbers:
  • 12-009407
First Posted:
Oct 29, 2012
Last Update Posted:
Jun 29, 2015
Last Verified:
Jun 1, 2015
Keywords provided by Children's Hospital of Philadelphia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 29, 2015